Skip to main content
×
×
Home

Sodium valproate or valproate semisodium: is there a difference in the treatment of bipolar disorder?

  • Chris Fisher (a1) and Wendy Broderick (a1)
Extract

The ‘off licence’ use of drugs is common in the UK. One such use is the treatment of bipolar disorder with sodium valproate. This paper reviews the evidence for using the licensed alternative, valproate semisodium, under the headings of licence, efficacy, pharmacokinetics and tolerability.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Sodium valproate or valproate semisodium: is there a difference in the treatment of bipolar disorder?
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Sodium valproate or valproate semisodium: is there a difference in the treatment of bipolar disorder?
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Sodium valproate or valproate semisodium: is there a difference in the treatment of bipolar disorder?
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
Bowden, C., Brugger, A., Swann, A., et al (1994) Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA, 271, 918924.
Bowden, C., Calabrese, J., McElroy, S., et al (2000) A randomised placebo controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Archives of General Psychiatry, 57, 481489.
Brasfield, K. (1999) Pilot study of divalproex sodium versus valproic acid drug acquisition costs versus all related costs. Current Therapeutic Research, 60, 138144.
Brown, C., Wang, J. & Young, L. (2000) Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat glioma cells. Neuropharmacology, 39, 21622169.
Davis, L., Ryan, W., Adinoff, B., et al (2000) Comprehensive review of the psychiatric uses of valproate. Journal of Clinical Psychopharmacology, 20, (suppl. 1), 1–17s.
Demoulin, L. & Landry, P. (2000) Plasma concentration of valproate following substitution of divalproex sodium by valproic acid. Canadian Journal of Psychiatry, 45, 761.
Department of Health (2002) Drug Tariff, January 2002. London: DoH.
Douglas-Hall, P., Fuller, A. & Gill-Banham, S. (2001) An analysis of off-licence prescribing in psychiatric medicine. Pharmaceutical Journal, 267, 890891.
Food and Drug Administration (2002) Depakote®Tablets. http://www.accessdata.fda.gov/scripts/cder/ob/docs/temptn.cfm.
Freeman, T., Clothier, J., Pazzaglia, P., et al (1992) A double blind comparison of valproate in the treatment of acute mania. American Journal of Psychiatry, 149, 108111.
Lambert, P. & Venaud, G. (1992) Etude comparative du valpromide versus lithium dans la prophylaxie des troubles thymiques. Nervure, 5, 5765.
Macritchie, K., Geddes, J., Scott, J., et al (2001) Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder (Cochrane Review). Cochrane Library, issue 4. Oxford: Update Software.
MIMS (2002) Monthly Index of Medical Specialities, January. London: Haymarket.
Perry, P., Bever-Stille, K., Arndt, S., et al (2000) Correlation of valproate plasma concentrations and dose in bipolar affective disorder. Journal of Clinical Psychopharmacology, 20, 277279.
Perucca, E. (2002) Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs, 16, 695714.
Pope, H., McElroy, S., Keck, P., et al (1991) Valproate in the treatment of acute mania: a placebo controlled study. Archives of General Psychiatry, 46, 6268.
Roberts, D., Easter, D. & O'Bryantear, G. (1996) Epilim Chrono: a multidose crossover comparison of two formulations of valproate in healthy volunteers. Biopharmaceutics and Drug Disposition, 17, 175182.
Sanofi–Synthelabo (2001) Summary of Product Characteristics–Depakote ®. January 2001. http://www.sanofi-synthelabo.co.uk.
Taylor, D., McConnell, H., Duncan-McConnell, D. et al (2001) The Maudsley Prescribing Guidelines (6th edn). London: Martin Dunitz.
Watson, D., Watterson, J. & Lennox, R. (1998) Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalised hippocampal cells: a property of protein kinase C-mediated mood stabilisers. Journal of Pharmacology and Experimental Therapeutics, 285, 307316.
Zaccara, G., Messori, A. & Moroni, F. (1988) Clinical pharmacokinetics of valproic acid – 1988. Clinical Pharmacokinetics, 15, 367389.
Zarate, C., Tohen, M., Narendran, R., et al (1999) The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study. Journal of Clinical Psychiatry, 60, 232236.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 18
Total number of PDF views: 123 *
Loading metrics...

Abstract views

Total abstract views: 828 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 23rd July 2018. This data will be updated every 24 hours.

Sodium valproate or valproate semisodium: is there a difference in the treatment of bipolar disorder?

  • Chris Fisher (a1) and Wendy Broderick (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *